Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gaylor

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Medical & Biological Engineering|January 1, 1970
Kinetics of solute transfer from whole blood in a haemodialyserJ D Gaylor, W M Muir, W T Allen
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 30, 2001
Threshold analysis of selected dose-response data for endocrine active chemicalsR M Blair, H Fang, D Gaylor, et al.
Biochemical Society Transactions|May 1, 1996
The effect of oxygen concentration on the function of human Hep G2 hepatoma cells and primary cultures of rat hepatocytesH Grant, A D Smirthwaite, J D Gaylor, et al.
The International Journal of Artificial Organs|April 1, 1991
An in vitro technique to assess oxygenator potential for respiratory failure therapiesA M Kawak, J D Gaylor, K Simpson, et al.
Perfusion|May 1, 1994
Membrane oxygenators: influence of design on performanceJ D Gaylor, S Hickey, G Bell, et al.
Perfusion|January 1, 1994
Biomaterials in cardiopulmonary bypassJ M Courtney, S Sundaram, B M Matata, et al.
Mutation Research|July 24, 1998
Use of Druckrey analysis to quantitatively evaluate the chemopreventive efficacy of N-difluoromethylornithine (DFMO), a prototype proliferation inhibitorC W Boone, V E Steele, D Gaylor, et al.
Biochemical Society Transactions|February 1, 1993
Growth and viability of Hep G2 cells in medium containing high serum concentrationsA Melkonian, J D Gaylor, R B Cousins, et al.
Journal of Biomedical Engineering|September 1, 1992
Development of a digital adaptive control system for PO2 regulation in a membrane oxygenatorJ Allen, A C Fisher, J D Gaylor, et al.
Artificial Organs|August 1, 1994
Culture of a differentiated liver cell line, Hep G2, in serum with application to a bioartificial liver: effect of supplementation of serum with amino acidsA D Melkonian, J D Gaylor, R B Cousins, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Medical & Biological Engineering|January 1, 1970
Kinetics of solute transfer from whole blood in a haemodialyserJ D Gaylor, W M Muir, W T Allen
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 30, 2001
Threshold analysis of selected dose-response data for endocrine active chemicalsR M Blair, H Fang, D Gaylor, et al.
Biochemical Society Transactions|May 1, 1996
The effect of oxygen concentration on the function of human Hep G2 hepatoma cells and primary cultures of rat hepatocytesH Grant, A D Smirthwaite, J D Gaylor, et al.
The International Journal of Artificial Organs|April 1, 1991
An in vitro technique to assess oxygenator potential for respiratory failure therapiesA M Kawak, J D Gaylor, K Simpson, et al.
Perfusion|May 1, 1994
Membrane oxygenators: influence of design on performanceJ D Gaylor, S Hickey, G Bell, et al.
Perfusion|January 1, 1994
Biomaterials in cardiopulmonary bypassJ M Courtney, S Sundaram, B M Matata, et al.
Mutation Research|July 24, 1998
Use of Druckrey analysis to quantitatively evaluate the chemopreventive efficacy of N-difluoromethylornithine (DFMO), a prototype proliferation inhibitorC W Boone, V E Steele, D Gaylor, et al.
Biochemical Society Transactions|February 1, 1993
Growth and viability of Hep G2 cells in medium containing high serum concentrationsA Melkonian, J D Gaylor, R B Cousins, et al.
Journal of Biomedical Engineering|September 1, 1992
Development of a digital adaptive control system for PO2 regulation in a membrane oxygenatorJ Allen, A C Fisher, J D Gaylor, et al.
Artificial Organs|August 1, 1994
Culture of a differentiated liver cell line, Hep G2, in serum with application to a bioartificial liver: effect of supplementation of serum with amino acidsA D Melkonian, J D Gaylor, R B Cousins, et al.
Pageof 7